Open-label, non-randomised, single dose study in 6 healthy male subjects to assess the mass balance recovery, metabolite profile, metabolite identification and pharmacokinetics of 14C-labelled APD421
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
PRA Health Sciences
Groningen, Netherlands
Mass Balance
Mean recovery of radioactivity in excreta after a single intravenous (IV) dose of carbon-14-labelled APD421
Time frame: 168 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.